Objective:

To examine the development of colorectal cancer liver metastases (CRLM) and explore recent therapeutic advances and emerging treatment strategies.

Approach:

• Review of CRLM: The review discusses the cellular and molecular mechanisms underlying CRLM and the immunosuppressive microenvironment of the liver.
• Therapeutic Advances: It highlights current treatment options including chemotherapy, radiotherapy, targeted therapy, and immunotherapy.
• Emerging Strategies: The review explores promising research and treatment strategies aimed at improving patient outcomes.

Key Findings:

• Liver metastasis is a principal cause of death in colorectal cancer patients, accounting for approximately 70% of fatal cases.
• The liver's immune-tolerant microenvironment facilitates metastatic colonization and therapeutic resistance.
• CRLM develops through a multistep process involving primary tumor invasion, immune evasion, and colonization.

Interpretation:

A deeper understanding of CRLM pathogenesis and therapeutic progress is essential for optimizing treatment approaches.

Limitations:

• The review does not provide specific clinical trial data or outcomes related to the discussed therapies.
• Emerging treatment strategies may require further validation in clinical settings.

Conclusion:

Understanding the mechanisms of CRLM and the liver's immunosuppressive environment can inform future therapeutic strategies.